Gastrin-releasing peptide signaling alters colon cancer invasiveness via heterochromatin protein 1Hsβ

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 672-678

  Tell, Robert ^a   Rivera, Claudio A ^a   Eskra, Jillian ^a   Taglia, Lauren N ^a   Blunier, Adam ^a   Wang, Q Tian ^a   Benya, Richard V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; HETEROCHROMATIN PROTEIN 1; PEROXIDASE;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CELL INVASION; COLON CANCER; DOWN REGULATION; EPIGENETICS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR CELL; WESTERN BLOTTING;

EID: 79951844951     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.10.017     Document Type: Article

References (38)

1. Carroll RE, Matkowskyj KA, Saunthararajah Y, Sekosan M, Battey JF, Benya RV: Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract. Mech Dev 2002, 113:121-130 (Pubitemid 34311738)
2. Rivera CA, Ahlberg NC, Taglia L, Kumar M, Blunier A, Benya RV: Expression of GRP and its receptor is associated with improved survival in patients with colon cancer. Clin Exp Metastasis 2009, 26:663-671
3. Eissenberg JC, Elgin SC: The HP1 protein family: getting a grip on chromatin. Curr Opin Genet Dev 2000, 10:204-210 (Pubitemid 30182255)
4. Paro R, Hogness DS: The polycomb protein shares a homologous domain with a heterochromatin-associated protein of Drosophila. Proc Natl Acad Sci USA 1991, 88:263-267 (Pubitemid 21914467)
5. Grewal SI, Jia S: Heterochromatin revisited. Nat Rev Genet 2007, 8:35-46 (Pubitemid 46006048)
6. Dillon N: Heterochromatin structure and function. Biol Cell 2004, 96:631-637
7. Dialynas GK, Vitalini MW, Wallrath LL: Linking heterochromatin protein 1 (HP1) to cancer progression. Mutat Res 2008, 647:13-20
8. Takanashi M, Oikawa K, Fujita K, Kudo M, Kinoshita M, Kuroda M: Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers. Am J Pathol 2009, 174:309-316
9. Qin Y, Ertl T, Cai RZ, Halmos G, Schally AV: Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res 1994, 54: 1035-1041 (Pubitemid 24085459)
10. Roesler R, Kopschina MI, Rosa RM, Henriques JA, Souza DO, Schwartsmann G: RC-3095, a bombesin/gastrin-releasing peptide receptor antagonist, impairs aversive but not recognition memory in rats. Eur J Pharmacol 2004, 486:35-41 (Pubitemid 38130159)
11. Matkowskyj KA, Schonfeld D, Benya RV: Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software Photoshop and Matlab. J Histochem Cytochem 2000, 48:303-311 (Pubitemid 30127068)
12. Matkowskyj KA, Cox R, Jensen RT, Benya RV: Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures protein concentration. J Histochem Cytochem 2003, 51: 205-214 (Pubitemid 36160047)
13. Matkowskyj KA, Cox R, Benya RV: Quantitative immunohistochemistry by determining the norm of the image file. Edited by MA Hayat. Burlington, MA, Academic Press, 2006, pp 279-284
14. Matkowskyj K, Glover S, Benya R: Quantitative immunohistochemistry: an algorithm measuring cumulative signal strength and receptor number. Microsc Anal 2004, 18:5-6
15. Taglia L, Matusiak D, Matkowskyj KA, Benya RV: Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by up-regulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase. Am J Physiol 2007, 292:G182-G190 (Pubitemid 46091629)
16. Itoh F, Yamamoto H, Hinoda Y, Imai K: Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells. Cancer 1996, 77:1717-1721 (Pubitemid 26111858)
17. Zhu XL, Liang L, Ding YQ: Overexpression of FMNL2 is closely related to metastasis of colorectal cancer. Int J Colorectal Dis 2008, 23:1041-1047
18. Ruginis TA, Taglia L, Matusiak D, Bao-Shiang L, Benya RV: Consequence of gastrin-releasing peptide receptor activation in a human colon cancer cell line: a proteomic approach. J Proteome Res 2006, 5:1460-1468 (Pubitemid 43865814)
19. Matkowskyj KA, Keller K, Glover S, Kornberg L, Tran-Son-Tay R, Benya RV: Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407. J Histochem Cytochem 2003, 51:1041-1048 (Pubitemid 36919981)
20. Carroll RE, Matkowskyj KA, Chakrabarti S, McDonald TJ, Benya RV: Aberrant expression of gastrin-releasing peptide and its receptor by well differentiated colon cancers in humans. Am J Physiol 1999, 276:G655-G665 (Pubitemid 29157431)
21. Kirschmann DA, Lininger RA, Gardner LM, Seftor EA, Odero VA, Ainsztein AM, Earnshaw WC, Wallrath LL, Hendrix MJ: Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer. Cancer Res 2000, 60:3359-3363 (Pubitemid 30482146)
22. Norwood LE, Moss TJ, Margaryan NV, Cook SL, Wright L, Seftor EA, Hendrix MJ, Kirschmann DA, Wallrath LL: A requirement for dimerization of HP1Hsalpha in suppression of breast cancer invasion. J Biol Chem 2006, 281:18668-18676 (Pubitemid 44035527)
23. Lomberk G, Wallrath L, Urrutia R: The heterochromatin protein 1 family. Genome Biol 2006, 7:228
24. Olins DE, Olins AL: Granulocyte heterochromatin: defining the epigenome. BMC Cell Biol 2005, 6:39
25. Panteleeva I, Boutillier S, See V, Spiller DG, Rouaux C, Almouzni G, Bailly D, Maison C, Lai HC, Loeffler JP, Boutillier AL: HP1alpha guides neuronal fate by timing E2F-targeted genes silencing during terminal differentiation. EMBO J 2007, 26:3616-3628 (Pubitemid 47236874)
26. Norwood LE, Grade SK, Cryderman DE, Hines KA, Furiasse N, Toro R, Li Y, Dhasarathy A, Kladde MP, Hendrix MJ, Kirschmann DA, Wallrath LL: Conserved properties of HP1(Hsalpha). Gene 2004, 336:37-46
27. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002, 415:436-442 (Pubitemid 34100955)
28. Moss TJ, Wallrath LL: Connections between epigenetic gene silencing and human disease. Mutat Res 2007, 618:163-174 (Pubitemid 46584694)
29. Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M: Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003, 4:51-62 (Pubitemid 36621624)
30. Berger JC, Vander Griend DJ, Robinson VL, Hickson JA, Rinker- Schaeffer CW: Metastasis suppressor genes: from gene identification to protein function and regulation. Cancer Biol Ther 2005, 4:805-812
31. Nishimura K, Hirokawa YS, Mizutani H, Shiraishi T: Reduced heterochromatin protein 1-beta (HP1beta) expression is correlated with increased invasive activity in human melanoma cells. Anticancer Res 2006, 26:4349-4356 (Pubitemid 46031508)
32. Erspamer V: Discovery, isolation and characterization of bombesin-like peptides. Ann NY Acad Sci 1988, 547:3-9
33. Erspamer V, Erspamer GF, Inslevini M, Negri L: Occurrence of bombesin and alytensin in extracts of the skin of three European discoglossid frogs and pharmacological actions of bombesin on extravascular smooth muscle. Br J Pharmacol 1972, 45:333-348
34. Jensen RT, Battey JF, Spindel ER, Benya RV: International Union of Pharmacology. LXVIII Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 2008, 60:1-42
35. Jensen JG, Carroll RE, Benya RV: The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer. Peptides 2001, 22:689-699 (Pubitemid 32322728)
36. Carroll RE, Carroll R, Benya RV: Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas. Peptides 1999, 20:229-237 (Pubitemid 29332105)
37. Toi-Scott M, Jones CL, Kane MA: Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells. Lung Cancer 1996, 15:341-354 (Pubitemid 26399513)
38. + natural killer cell binding to colon cancer cells causing tumor cell cytolysis. Clin Exp Metastasis 2008, 25:451-463